Iperionx Ltd. (IPX) intrinsic value & 10-year financials
Iperionx Ltd. (IPX) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -520.0%
- Free cash flow (FY2025)
- -$38.8M
IPX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$35.3M | -$0.12 | -$38.8M | — | -115.4% |
| FY2024 | — | -$21.8M | -$0.10 | -$23.6M | — | -149.2% |
| FY2023 | — | -$17.4M | -$0.11 | -$17.9M | — | -293.4% |
| FY2022 | — | -$21.5M | -$0.16 | -$13.0M | — | -1522.0% |
| FY2021 | — | — | — | — | — | — |
| FY2020 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
IPERIONX Ltd revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
IPERIONX Ltd has historically struggled to out-earn its cost of capital, averaging just -70.7% ROIC.
IPERIONX Ltd capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
IPERIONX Ltd is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.